Edward T. Mathers - Mar 31, 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
Director
Signature
/s/ Zachary Bambach, attorney-in-fact
Stock symbol
OKUR
Transactions as of
Mar 31, 2025
Transactions value $
$0
Form type
4
Date filed
4/2/2025, 04:48 PM
Previous filing
Mar 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OKUR Class A Common Stock Award $0 +2.58K $0.00 2.58K Mar 31, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. The RSUs were granted to the Reporting Person in lieu of a quarterly cash retainer, at the election of the Reporting Person, under the Issuer's Outside Director Compensation Policy.